NCT00172809View on ClinicalTrials.gov

Interferon Treatment for Patients With Chronic Hepatitis C and End Stage Renal Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

June 30, 2006

Study Completion Date

January 31, 2007

Conditions
Chronic Hepatitis CEnd Stage Renal Disease
Interventions
DRUG

Peginterferon alfa-2a

Peginterferon alfa-2a 135 ug/week for 24 weeks

DRUG

Interferon alfa-2a

Interferon alfa-2a 3 MU tiw for 24 weeks

Trial Locations (1)

Unknown

National Taiwan University Hospital, Yun-Lin Branch, Douliu

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER

NCT00172809 - Interferon Treatment for Patients With Chronic Hepatitis C and End Stage Renal Disease | Biotech Hunter | Biotech Hunter